Back to search

Article

Controversy on the Management of Patients Carrying RET p.V804M Mutation

2021-08-17

Abstract excerpt

<title>Abstract</title> <p><bold>Context:</bold><italic> RET</italic> p.V804M is classified as a moderate-risk mutation for familial medullary thyroid cancer (FMTC). There is a significant controversy on the management of patients carrying this mutation. We describe a family incidentally discovered to have this mutation during evaluation of a newborn with dysmorphic features. We provide a comprehensive literature...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
579fc2a2-e1ba-514e-9093-43375cbec00d
DOI
10.21203/rs.3.rs-799440/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Controversy on the Management of Patients Carrying RET p.V804M MutationDOI 10.21203/rs.3.rs-799440/v1
Select a neighboring publication to make it the new centre.